Peroxisomes
Peroxisomes
Peroxisomes
Protein Import into the Peroxisomes
Radical Autoxidation
Autoxidation of Ethers to Peroxides and Hydroperoxides
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 18, 2026

Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes
Published on: December 19, 2025
Vasily D Antonenkov1, Silke Grunau, Steffen Ohlmeier
1Department of Biochemistry, University of Oulu, Oulu, Finland. vasily.antonenkov@oulu.fi
Peroxisomes are small cell structures that handle reactive oxygen species (ROS), which can be harmful in large amounts. This review summarizes how peroxisomes both create and break down ROS, and what happens when this process is disrupted. The authors looked at conditions like hypocatalasemia and peroxisome proliferation, which can lead to ROS imbalances. They also explored how peroxisomal ROS might contribute to mitochondrial dysfunction, neurological issues, heart problems, and aging. The review suggests that understanding peroxisomal ROS metabolism could help explain disease mechanisms and guide future research.
Area of Science:
Background:
Peroxisomes function in cellular metabolism and ROS regulation. Prior research has shown their role in fatty acid oxidation and ROS decomposition. However, the full extent of their contribution to oxidative stress remains unclear. This gap motivated investigations into peroxisomal enzyme systems. No prior work had resolved how peroxisomal ROS interacts with mitochondrial dysfunction. Researchers have explored peroxisomal roles in disease but lacked a synthesis. The connection between peroxisomal metabolism and aging is still debated. This paper addresses unresolved questions about peroxisomal ROS dynamics.
Purpose Of The Study:
The authors aimed to synthesize evidence on peroxisomal ROS metabolism. They focused on enzymes involved in ROS production and defense. The study sought to clarify how peroxisomal dysfunction affects health. They examined conditions like hypocatalasemia and peroxisome proliferation. The goal was to link peroxisomal ROS to mitochondrial and neurological disorders. They also aimed to highlight peroxisomal roles in aging and cardiomyopathy. The review approach combined literature analysis with disease-specific case studies. This synthesis aimed to guide future research directions.
Main Methods:
The review approach included a comprehensive analysis of published literature. The authors examined enzymatic pathways in peroxisomal ROS metabolism. They evaluated antioxidant systems in mammalian peroxisomes. They analyzed conditions causing ROS imbalance in peroxisomes. The study incorporated data on peroxisomal biogenesis defects. Hypocatalasemia and peroxisome proliferation were key areas of focus. The authors synthesized findings on peroxisomal involvement in disease. They organized evidence around physiological and pathological processes.
Main Results:
Key findings from the literature show peroxisomes generate and decompose ROS. The review identified specific ROS-producing enzymes in peroxisomes. Antioxidative defenses include catalase and peroxiredoxins. Disturbances in peroxisomal biogenesis disrupt ROS balance. Hypocatalasemia leads to ROS accumulation in peroxisomes. Peroxisome proliferation correlates with oxidative stress. The literature suggests peroxisomal ROS affects mitochondrial function. Altered peroxisomal ROS is linked to aging and cardiomyopathy.
Conclusions:
Synthesis and implications suggest peroxisomal ROS metabolism is complex. The authors propose peroxisomal dysfunction contributes to disease. They suggest peroxisomal ROS may influence mitochondrial abnormalities. The review implies peroxisomal ROS may affect cell proliferation. Altered peroxisomal ROS may impact the central nervous system. The study suggests a role in alcoholic cardiomyopathy. The authors propose peroxisomal ROS may be involved in aging. These findings may guide future research on peroxisomal metabolism.
Peroxisomes both generate and decompose reactive oxygen species, as shown in the literature.
Hypocatalasemia leads to reduced ROS decomposition, increasing peroxisomal ROS accumulation.
Abnormal peroxisomal biogenesis disrupts ROS metabolism, as per the literature.
Catalase is a key enzyme in peroxisomal ROS decomposition, as the authors propose.
The literature suggests peroxisomal ROS may contribute to mitochondrial abnormalities.
The authors propose peroxisomal ROS may be involved in aging-related processes.